Item request has been placed!
×
Item request cannot be made.
×

Processing Request
Supplementary Material for Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
- Author(s): Bouzas, Adrián; Gómez de Cedrón, Marta; Colmenarejo, Gonzalo; Laparra, José Moisés; Moreno-Rubio, Juan; Montoya, Juan Jose; Reglero, Guillermo; Casado, Enrique; Tabares, Beatriz; Sereno, María; Ramírez de Molina, Ana
- Document Type:
Electronic Resource
- Online Access:
http://hdl.handle.net/10261/311284
Bouzas, Adrián; Gómez de Cedrón, Marta; Colmenarejo, Gonzalo; Laparra, José Moisés; Moreno-Rubio, Juan; Montoya, Juan Jose; Reglero, Guillermo; Casado, Enrique; Tabares, Beatriz; Sereno, María; Ramírez de Molina, Ana; 2022; Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic; https://doi.org/10.3389/fonc.2022.1046369; http://hdl.handle.net/10261/303010
Sí
- Additional Information
- Publisher Information:
Frontiers Media 2022
- Subject Terms:
- Availability:
Open access content. Open access content
http://creativecommons.org/licenses/by/4.0
openAccess
- Note:
English
- Other Numbers:
CTK oai:digital.csic.es:10261/311284
Bouzas, Adrián; Gómez de Cedrón, Marta; Colmenarejo, Gonzalo; Laparra, José Moisés; Moreno-Rubio, Juan; Montoya, Juan Jose; Reglero, Guillermo; Casado, Enrique; Tabares, Beatriz; Sereno, María; Ramírez de Molina, Ana; 2022; Supplementary Material for Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic [Dataset]; Frontiers Media; https://doi.org/10.3389/fonc.2022.1046369
10.3389/fonc.2022.1046369
1395197615
- Contributing Source:
CSIC
From OAIster®, provided by the OCLC Cooperative.
- Accession Number:
edsoai.on1395197615
HoldingsOnline
No Comments.